The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Calming and Sleeping-Global Market Insights and Sales Trends 2024
Synopsis
Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system.
The global Calming and Sleeping market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Calming and Sleeping in various end use industries. The expanding demands from the Insomnia, Sleep apnea, Restless Leg Syndrome (RLS) and Bruxism, are propelling Calming and Sleeping market. Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prescriptions segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Calming and Sleeping, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Calming and Sleeping market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Calming and Sleeping market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Calming and Sleeping sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Calming and Sleeping covered in this report include Eli Lilly, AstraZeneca, Johnson & Johnson, Sunovion Pharmaceuticals, Roscoe Medical, Acura Pharmaceuticals, Teva Pharmaceutical, Cara Therapeutics and Collegium Pharmaceutical, etc.
The global Calming and Sleeping market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
AstraZeneca
Johnson & Johnson
Sunovion Pharmaceuticals
Roscoe Medical
Acura Pharmaceuticals
Teva Pharmaceutical
Cara Therapeutics
Collegium Pharmaceutical
Durect
Global Calming and Sleeping market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Calming and Sleeping market, Segment by Type:
Medications
Prescriptions
Over-The-Counter (OTC)
Sleep Laboratories
Sleep Apnea Devices
Mattresses and Pillows
Global Calming and Sleeping market, by Application
Insomnia
Sleep apnea
Restless Leg Syndrome (RLS)
Bruxism
Narcolepsy
Sleepwalking
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Calming and sleeping products reduce tension and anxiety by inducing sedatives and a hypnotic effect on the body. They act by depressing the central nervous system.
The global Calming and Sleeping market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Calming and Sleeping in various end use industries. The expanding demands from the Insomnia, Sleep apnea, Restless Leg Syndrome (RLS) and Bruxism, are propelling Calming and Sleeping market. Medications, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prescriptions segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Calming and Sleeping, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Calming and Sleeping market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Calming and Sleeping market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Calming and Sleeping sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Calming and Sleeping covered in this report include Eli Lilly, AstraZeneca, Johnson & Johnson, Sunovion Pharmaceuticals, Roscoe Medical, Acura Pharmaceuticals, Teva Pharmaceutical, Cara Therapeutics and Collegium Pharmaceutical, etc.
The global Calming and Sleeping market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Eli Lilly
AstraZeneca
Johnson & Johnson
Sunovion Pharmaceuticals
Roscoe Medical
Acura Pharmaceuticals
Teva Pharmaceutical
Cara Therapeutics
Collegium Pharmaceutical
Durect
Global Calming and Sleeping market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Calming and Sleeping market, Segment by Type:
Medications
Prescriptions
Over-The-Counter (OTC)
Sleep Laboratories
Sleep Apnea Devices
Mattresses and Pillows
Global Calming and Sleeping market, by Application
Insomnia
Sleep apnea
Restless Leg Syndrome (RLS)
Bruxism
Narcolepsy
Sleepwalking
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Calming and Sleeping manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Calming and Sleeping in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Calming and Sleeping Market Overview
1.1 Calming and Sleeping Product Overview
1.2 Calming and Sleeping Market Segment by Type
1.2.1 Medications
1.2.2 Prescriptions
1.2.3 Over-The-Counter (OTC)
1.2.4 Sleep Laboratories
1.2.5 Sleep Apnea Devices
1.2.6 Mattresses and Pillows
1.3 Global Calming and Sleeping Market Size by Type
1.3.1 Global Calming and Sleeping Market Size Overview by Type (2018-2029)
1.3.2 Global Calming and Sleeping Historic Market Size Review by Type (2018-2023)
1.3.3 Global Calming and Sleeping Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Calming and Sleeping Sales Breakdown by Type (2018-2023)
1.4.2 Europe Calming and Sleeping Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Calming and Sleeping Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Type (2018-2023)
2 Global Calming and Sleeping Market Competition by Company
2.1 Global Top Players by Calming and Sleeping Sales (2018-2023)
2.2 Global Top Players by Calming and Sleeping Revenue (2018-2023)
2.3 Global Top Players by Calming and Sleeping Price (2018-2023)
2.4 Global Top Manufacturers Calming and Sleeping Manufacturing Base Distribution, Sales Area, Product Type
2.5 Calming and Sleeping Market Competitive Situation and Trends
2.5.1 Calming and Sleeping Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Calming and Sleeping Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Calming and Sleeping as of 2022)
2.7 Date of Key Manufacturers Enter into Calming and Sleeping Market
2.8 Key Manufacturers Calming and Sleeping Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Calming and Sleeping Status and Outlook by Region
3.1 Global Calming and Sleeping Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Calming and Sleeping Historic Market Size by Region
3.2.1 Global Calming and Sleeping Sales in Volume by Region (2018-2023)
3.2.2 Global Calming and Sleeping Sales in Value by Region (2018-2023)
3.2.3 Global Calming and Sleeping Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Calming and Sleeping Forecasted Market Size by Region
3.3.1 Global Calming and Sleeping Sales in Volume by Region (2024-2029)
3.3.2 Global Calming and Sleeping Sales in Value by Region (2024-2029)
3.3.3 Global Calming and Sleeping Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Calming and Sleeping by Application
4.1 Calming and Sleeping Market Segment by Application
4.1.1 Insomnia
4.1.2 Sleep apnea
4.1.3 Restless Leg Syndrome (RLS)
4.1.4 Bruxism
4.1.5 Narcolepsy
4.1.6 Sleepwalking
4.2 Global Calming and Sleeping Market Size by Application
4.2.1 Global Calming and Sleeping Market Size Overview by Application (2018-2029)
4.2.2 Global Calming and Sleeping Historic Market Size Review by Application (2018-2023)
4.2.3 Global Calming and Sleeping Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Calming and Sleeping Sales Breakdown by Application (2018-2023)
4.3.2 Europe Calming and Sleeping Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Calming and Sleeping Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Calming and Sleeping Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Calming and Sleeping Sales Breakdown by Application (2018-2023)
5 North America Calming and Sleeping by Country
5.1 North America Calming and Sleeping Historic Market Size by Country
5.1.1 North America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Calming and Sleeping Sales in Volume by Country (2018-2023)
5.1.3 North America Calming and Sleeping Sales in Value by Country (2018-2023)
5.2 North America Calming and Sleeping Forecasted Market Size by Country
5.2.1 North America Calming and Sleeping Sales in Volume by Country (2024-2029)
5.2.2 North America Calming and Sleeping Sales in Value by Country (2024-2029)
6 Europe Calming and Sleeping by Country
6.1 Europe Calming and Sleeping Historic Market Size by Country
6.1.1 Europe Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Calming and Sleeping Sales in Volume by Country (2018-2023)
6.1.3 Europe Calming and Sleeping Sales in Value by Country (2018-2023)
6.2 Europe Calming and Sleeping Forecasted Market Size by Country
6.2.1 Europe Calming and Sleeping Sales in Volume by Country (2024-2029)
6.2.2 Europe Calming and Sleeping Sales in Value by Country (2024-2029)
7 Asia-Pacific Calming and Sleeping by Region
7.1 Asia-Pacific Calming and Sleeping Historic Market Size by Region
7.1.1 Asia-Pacific Calming and Sleeping Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Calming and Sleeping Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Calming and Sleeping Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Calming and Sleeping Forecasted Market Size by Region
7.2.1 Asia-Pacific Calming and Sleeping Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Calming and Sleeping Sales in Value by Region (2024-2029)
8 Latin America Calming and Sleeping by Country
8.1 Latin America Calming and Sleeping Historic Market Size by Country
8.1.1 Latin America Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Calming and Sleeping Sales in Volume by Country (2018-2023)
8.1.3 Latin America Calming and Sleeping Sales in Value by Country (2018-2023)
8.2 Latin America Calming and Sleeping Forecasted Market Size by Country
8.2.1 Latin America Calming and Sleeping Sales in Volume by Country (2024-2029)
8.2.2 Latin America Calming and Sleeping Sales in Value by Country (2024-2029)
9 Middle East and Africa Calming and Sleeping by Country
9.1 Middle East and Africa Calming and Sleeping Historic Market Size by Country
9.1.1 Middle East and Africa Calming and Sleeping Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Calming and Sleeping Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Calming and Sleeping Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Calming and Sleeping Forecasted Market Size by Country
9.2.1 Middle East and Africa Calming and Sleeping Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Calming and Sleeping Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Introduction and Business Overview
10.1.3 Eli Lilly Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly Calming and Sleeping Products Offered
10.1.5 Eli Lilly Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Introduction and Business Overview
10.2.3 AstraZeneca Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca Calming and Sleeping Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Johnson & Johnson
10.3.1 Johnson & Johnson Company Information
10.3.2 Johnson & Johnson Introduction and Business Overview
10.3.3 Johnson & Johnson Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Johnson & Johnson Calming and Sleeping Products Offered
10.3.5 Johnson & Johnson Recent Development
10.4 Sunovion Pharmaceuticals
10.4.1 Sunovion Pharmaceuticals Company Information
10.4.2 Sunovion Pharmaceuticals Introduction and Business Overview
10.4.3 Sunovion Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sunovion Pharmaceuticals Calming and Sleeping Products Offered
10.4.5 Sunovion Pharmaceuticals Recent Development
10.5 Roscoe Medical
10.5.1 Roscoe Medical Company Information
10.5.2 Roscoe Medical Introduction and Business Overview
10.5.3 Roscoe Medical Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Roscoe Medical Calming and Sleeping Products Offered
10.5.5 Roscoe Medical Recent Development
10.6 Acura Pharmaceuticals
10.6.1 Acura Pharmaceuticals Company Information
10.6.2 Acura Pharmaceuticals Introduction and Business Overview
10.6.3 Acura Pharmaceuticals Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Acura Pharmaceuticals Calming and Sleeping Products Offered
10.6.5 Acura Pharmaceuticals Recent Development
10.7 Teva Pharmaceutical
10.7.1 Teva Pharmaceutical Company Information
10.7.2 Teva Pharmaceutical Introduction and Business Overview
10.7.3 Teva Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Teva Pharmaceutical Calming and Sleeping Products Offered
10.7.5 Teva Pharmaceutical Recent Development
10.8 Cara Therapeutics
10.8.1 Cara Therapeutics Company Information
10.8.2 Cara Therapeutics Introduction and Business Overview
10.8.3 Cara Therapeutics Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Cara Therapeutics Calming and Sleeping Products Offered
10.8.5 Cara Therapeutics Recent Development
10.9 Collegium Pharmaceutical
10.9.1 Collegium Pharmaceutical Company Information
10.9.2 Collegium Pharmaceutical Introduction and Business Overview
10.9.3 Collegium Pharmaceutical Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Collegium Pharmaceutical Calming and Sleeping Products Offered
10.9.5 Collegium Pharmaceutical Recent Development
10.10 Durect
10.10.1 Durect Company Information
10.10.2 Durect Introduction and Business Overview
10.10.3 Durect Calming and Sleeping Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Durect Calming and Sleeping Products Offered
10.10.5 Durect Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Calming and Sleeping Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Calming and Sleeping Industrial Chain Analysis
11.4 Calming and Sleeping Market Dynamics
11.4.1 Calming and Sleeping Industry Trends
11.4.2 Calming and Sleeping Market Drivers
11.4.3 Calming and Sleeping Market Challenges
11.4.4 Calming and Sleeping Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Calming and Sleeping Distributors
12.3 Calming and Sleeping Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
